The Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008. An assessment by the Australian and New Zealand Intensive Care Society

Dellinger R.P. , Levy M.M. , Carlet J.M. , Bion J. , Parker M.M. , Jaeschke R. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17–60.

Dellinger R.P. , Levy M.M. , Carlet J.M. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.

Rivers E. , Nguyen B. , Havstad S. , Ressler J. , Muzzin A. , Knoblich B. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–1377.

van den Berghe G. , Wouters P. , Weekers F. , Verwaest C. , Bruyninckx F. , Schetz M. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–1367.

van den Berghe G. , Wilmer A. , Hermans G. , Meersseman W. , Wouters P.J. , Milants I. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449–461.

Brunkhorst F.M. , Engel C. , Bloos F. , Meier-Hellmann A. , Ragaller M. , Weiler N. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125–139.

Annane D. , Sébille V. , Charpentier C. , Bollaert P.E. , François B. , Korach J.M. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–871.

Sprung C.L. , Annane D. , Keh D. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111–124.

Bernard G.R. , Vincent J.L. , Laterre P.F. , LaRosa S.P. , Dhainaut J.F. , Lopez-Rodriguez A. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.

Eichacker P.Q. , Natanson C. , Danner R.L. Surviving sepsis—practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 2006; 355: 1640–1642.

Myburgh J.A. , Higgins A. , Jovanovska A. , Lipman J. , Ramakrishnan N. , Santamaria J. A comparison of epinephrine and norepinephrine on reversal of shock. Intensive Care Med 2007; 33: S197

Bellomo R. , Chapman M. , Finfer S. , Hickling K. , Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139–2143.